Literature DB >> 8657107

Constitutive expression of Bc1-3 in thymocytes increases the DNA binding of NF-kappaB1 (p50) homodimers in vivo.

J H Caamaño1, P Perez, S A Lira, R Bravo.   

Abstract

Previous studies have indicated that Bcl-3 interacts through its ankyrin repeats with the transcriptional factors NF-kappaB1 (p50) and NF-kappaB2 (p52), affecting their biological activities. To further investigate the role of Bcl-3 in vivo and its association with the NF-kappaB proteins, we have generated transgenic mice constitutively expressing Bcl-3 in thymocytes. The results indicate that Bcl-3 is associated with endogenous p50 and p52 in nuclear extracts from transgenic animals. Remarkably, constitutive expression of Bcl-3 in these cells augments the DNA binding activity of p52 homodimers. This effect could be reproduced in vitro and is blocked by anti-Bcl-3 antibodies. We have also shown that Bcl-3 is phosphorylated in thymocytes and that its dephosphorylation greatly decreases the effect on p50 homodimers.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8657107      PMCID: PMC231118          DOI: 10.1128/MCB.16.4.1342

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  61 in total

1.  Functional dissection of the lck proximal promoter.

Authors:  J M Allen; K A Forbush; R M Perlmutter
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

2.  Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B.

Authors:  T Fujita; G P Nolan; S Ghosh; D Baltimore
Journal:  Genes Dev       Date:  1992-05       Impact factor: 11.361

3.  In vivo stimulation of I kappa B phosphorylation is not sufficient to activate NF-kappa B.

Authors:  I Alkalay; A Yaron; A Hatzubai; S Jung; A Avraham; O Gerlitz; I Pashut-Lavon; Y Ben-Neriah
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

4.  Expression of relB is required for the development of thymic medulla and dendritic cells.

Authors:  L Burkly; C Hession; L Ogata; C Reilly; L A Marconi; D Olson; R Tizard; R Cate; D Lo
Journal:  Nature       Date:  1995-02-09       Impact factor: 49.962

5.  NF-kappa B subunit regulation in nontransformed CD4+ T lymphocytes.

Authors:  S M Kang; A C Tran; M Grilli; M J Lenardo
Journal:  Science       Date:  1992-06-05       Impact factor: 47.728

6.  Tumor necrosis factor alpha-induced phosphorylation of I kappa B alpha is a signal for its degradation but not dissociation from NF-kappa B.

Authors:  S Miyamoto; M Maki; M J Schmitt; M Hatanaka; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

7.  The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.

Authors:  E N Hatada; A Nieters; F G Wulczyn; M Naumann; R Meyer; G Nucifora; T W McKeithan; C Scheidereit
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

8.  scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice.

Authors:  L Robb; J E Rasko; M L Bath; A Strasser; C G Begley
Journal:  Oncogene       Date:  1995-01-05       Impact factor: 9.867

9.  Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses.

Authors:  W C Sha; H C Liou; E I Tuomanen; D Baltimore
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

10.  Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family.

Authors:  F Weih; D Carrasco; S K Durham; D S Barton; C A Rizzo; R P Ryseck; S A Lira; R Bravo
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

View more
  31 in total

1.  Crystal structure of the ankyrin repeat domain of Bcl-3: a unique member of the IkappaB protein family.

Authors:  F Michel; M Soler-Lopez; C Petosa; P Cramer; U Siebenlist; C W Müller
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

Review 2.  Role of T cell-nuclear factor κB in transplantation.

Authors:  Luciana L Molinero; Maria-Luisa Alegre
Journal:  Transplant Rev (Orlando)       Date:  2011-11-08       Impact factor: 3.943

Review 3.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

4.  Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-kappa B.

Authors:  J Anrather; V Csizmadia; C Brostjan; M P Soares; F H Bach; H Winkler
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

5.  Bcl-3 expression promotes cell survival following interleukin-4 deprivation and is controlled by AP1 and AP1-like transcription factors.

Authors:  A Rebollo; L Dumoutier; J C Renauld; A Zaballos; V Ayllón; C Martínez-A
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

6.  C/EBPα and C/EBPα oncoproteins regulate nfkb1 and displace histone deacetylases from NF-κB p50 homodimers to induce NF-κB target genes.

Authors:  Ido Paz-Priel; Simone Houng; Julia Dooher; Alan D Friedman
Journal:  Blood       Date:  2011-02-23       Impact factor: 22.113

7.  Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets.

Authors:  A S Weyrich; D A Dixon; R Pabla; M R Elstad; T M McIntyre; S M Prescott; G A Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

Review 8.  Regulation of serum amyloid A protein expression during the acute-phase response.

Authors:  L E Jensen; A S Whitehead
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

9.  High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis.

Authors:  Anne-Tove Brenne; Unn-Merete Fagerli; John D Shaughnessy; Thea Kristin Våtsveen; Torstein Baade Rø; Hanne Hella; Fenghuang Zhan; Bart Barlogie; Anders Sundan; Magne Børset; Anders Waage
Journal:  Eur J Haematol       Date:  2009-01-13       Impact factor: 2.997

10.  A novel role for IkappaBzeta in the regulation of IFNgamma production.

Authors:  Raquel M Raices; Yashaswini Kannan; Vedavathi Bellamkonda-Athmaram; Sudarshan Seshadri; Huating Wang; Denis C Guttridge; Mark D Wewers
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.